The healthcare industry is still reeling under the massive blow dealt by the COVID-19 pandemic. One subset of the healthcare sector that has witnessed increased adoption in many countries during the lockdown. The reason behind its increased adoption seems to be that it helps people in ways that are cost-effective and compliant with social-distancing guidelines.
Besides, shareholders, providers, payers, regulators, and investors, almost everyone have signaled their support for these products. According to a report, the global digital therapeutics market is projected to reach $6.9B (approx €5.87B) by 2025 from $2.1B (approx €1.78B) in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).